Keith Rodgers to Co-Chair 'Managing Complex Programmes in an increasingly challenging environment' Part 1 - 'Is Innovation our friend or foe?'
2 November 2023
Nanoforce's Chief Executive Officer, Keith Rodgers will be Co-Chairing the next Pharmaceutical Industry Project Management Group (PIPMG) meeting on Tuesday 28th November 2023 'Managing Complex Programmes in an increasingly challenging environment' Part 1 - 'Is Innovation our friend or foe?'. This meeting is kindly sponsored by UCB in Slough.
Please join us as we discuss how innovation is driving changes in product development and how project management can help manage the complexities.
We will hear from industry experts including Dr Dan Swerdlow, Senior Director Discovery Medicine (GSK) and Dr Panteli Theocharous, Chief Therapeutics Officer (Garuda Therapeutics), former Global VP Cell & Gene Therapy Strategy Lead (PPD) on topics including the use of platform technologies and genetics, complexities of the patient pathways and challenges in recruiting rare disease patients. This event is a mixture of presentations and the highly regarded PIPMG facilitated workshops on practical solutions and networking to share experiences via discussion and debate.
As science advances so do the challenges of generating data and navigating the path to approval and patients, don't miss the opportunity to hear about this.
Part 2 will be at White City in May 2024 and will continue the theme with a focus on alliances and collaborations between companies and patient groups. Look out for a special two meeting deal if you attend in November.
The agenda is available on the website. Book now to secure your place; early bird price available until 3rd November 2023
Updated by: David Lockwood